Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Implanon

Known as: Nourypharma brand of 3-keto-desogestrel, Organon brand of 3-keto-desogestrel 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
ObjectivesStudy was conducted to determine acceptability, efficacy, safety, return of fertility with Implanon.MethodsVolunteers… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2010
Highly Cited
2010
BACKGROUND This study was conducted to compare the incidence of repeat teenage pregnancy over a 24-month period postpartum among… Expand
Highly Cited
2009
Highly Cited
2009
BACKGROUND This study examined demographic profile, continuation rates and reasons for removal among Implanon users accessing two… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Review
2008
Review
2008
Objectives To evaluate the tolerability and clinical safety of the subdermal, long-acting hormonal contraceptive Implanon… Expand
Highly Cited
2005
Highly Cited
2005
OBJECTIVES The safety and efficacy of a single-rod implantable contraceptive containing etonogestrel (Implanontrade mark) were… Expand
  • figure 1
  • figure 2
  • table 2
  • figure 3
  • table 3
Highly Cited
2005
Highly Cited
2005
This paper describes a case series of over 200 unintended pregnancies associated with the etonogestrel implant, Implanon. These… Expand
Highly Cited
1999
Highly Cited
1999
To compare the contraceptive efficacy, tolerability, and bleeding patterns, 200 healthy female volunteers received, in an open… Expand
Highly Cited
1998
Highly Cited
1998
OBJECTIVE To study the mechanism of action of Implanon, a single-rod contraceptive implant containing etonogestrel, in healthy… Expand
Highly Cited
1998
Highly Cited
1998
Implanon is a single-rod contraceptive implant containing the progestin etonogestrel. Implants require insertion and removal by… Expand
Highly Cited
1998
Highly Cited
1998
This integrated analysis evaluates nonmenstrual adverse events, blood pressure, and body weight changes during the use of the… Expand